|
Jun 18
|
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
|
|
Feb 25
|
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
|
|
Jan 4
|
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
|
|
Dec 5
|
Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth
|
|
Jun 28
|
Here's Why We're Not Too Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Situation
|